Geltex Pharmaceuticals Inc

GelTex Pharmaceuticals Inc. develops and markets non-absorbed, polymer-based polymer drugs that selectively bind to and eliminate target substances from the intestinal tract. The Company markets RenaGel for the reduction of serum phos- phorus in patients on hemodialysis, and Cholestagel for the treatment of high blood cholesterol levels. GelTex is also developing an anti-obesity drug.